Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_003944342.1 C1M55_RS07295 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_002893965.1:WP_003944342.1 Length = 411 Score = 441 bits (1134), Expect = e-128 Identities = 241/395 (61%), Positives = 284/395 (71%), Gaps = 8/395 (2%) Query: 5 GTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLDG 64 GT L + RVM+LGSGELGKEV I QRLGVEVIAVDRY DAP VAHR+H ++M D Sbjct: 18 GTPLTENSIRVMMLGSGELGKEVVIALQRLGVEVIAVDRYPDAPGHQVAHRAHTVDMTDP 77 Query: 65 DALRRVVELEKPHYIVPEIEAIATDMLIQLEEEG-LNVVPCARATKLTMNREGIRRLAAE 123 +AL V+ELEKPH++VPEIEAIATD L +EE G V+P ARAT+LTMNREGIRRLAAE Sbjct: 78 EALLAVIELEKPHFVVPEIEAIATDALALVEERGGAVVIPTARATQLTMNREGIRRLAAE 137 Query: 124 ELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQQ 183 EL LPTS Y FADS + + A IG+PC++KPVMSSSGKGQ+ +RSAE L AW YA Sbjct: 138 ELGLPTSPYAFADSLAEVQAATDRIGFPCVIKPVMSSSGKGQSTVRSAEDLDAAWDYAMA 197 Query: 184 GGRAGAGRVIVEGVVKFDFEITLLTVSAVD-----GVHFCAPVGHRQEDGDYRESWQPQQ 238 GGR GRVIVEG V FD+EIT LTV AV FC P+GH QE GDY ESWQPQQ Sbjct: 198 GGRVNHGRVIVEGFVDFDYEITQLTVRAVGESGQVETSFCEPIGHLQEAGDYIESWQPQQ 257 Query: 239 MSPLALERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLS 298 MS +AL A+++A KV ALGG G+FGVELFV GD+V FSEVSPRPHDTG+VTL +Q LS Sbjct: 258 MSAVALASARDVAEKVTTALGGRGIFGVELFVKGDDVFFSEVSPRPHDTGLVTLRTQRLS 317 Query: 299 EFALHVRAFLGLPVGGIRQYGPAASAVILPQLTSQNVTFDNVQNAVGA-DLQIRLFGKPE 357 EF LH RA LGLPV P ASAVI + ++ + FD V A+ + +RLFGKPE Sbjct: 318 EFELHARAILGLPV-DTTLTSPGASAVIYGGVEAKGIGFDGVAEALAVPETDLRLFGKPE 376 Query: 358 IDGSRRLGVALATAESVVDAIERAKHAAGQVKVQG 392 RR+GVA++TA V A +RA+ AA +V+ G Sbjct: 377 SFTRRRMGVAVSTAADVPTARDRAREAASKVRPVG 411 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 449 Number of extensions: 17 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 411 Length adjustment: 31 Effective length of query: 361 Effective length of database: 380 Effective search space: 137180 Effective search space used: 137180 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory